Physician profile
Mohammad Memon
NPI 1932101755
$2,284.72
in general payments reported to CMS, 2019-2025
24 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $327 · 2021: $523 · 2022: $220 · 2023: $176 · 2024: $328 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $432.00 | 2020-2024 | Jardiance |
| Abbott Laboratories | $259.04 | 2019-2025 | Amplatzer Amulet, Cardiomems, Jot Dx |
| Janssen Pharmaceuticals, INC | $219.77 | 2019-2022 | |
| Novo Nordisk INC | $185.77 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $166.02 | 2020-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $154.65 | 2019-2025 | |
| Pfizer INC. | $121.71 | 2019-2025 | |
| Zoll Respicardia, INC. | $118.72 | 2023 | Remede System |
| E.R. Squibb & Sons, L.L.C. | $92.91 | 2022-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $92.21 | 2019-2024 | |
| Heartflow, INC. | $90.14 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $70.77 | 2020-2024 | Verquvo |
| Amarin Pharma, INC. | $52.39 | 2019-2020 | |
| G Medical Diagnostic Services, INC. | $44.27 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $40.97 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $27.22 | 2019-2021 | |
| Vital Connect, INC | $19.18 | 2025 | Vitalpatch Rtm |
| Exact Sciences Corporation | $18.50 | 2025 | Cologuard Collection Kit |
| Abiomed | $16.33 | 2025 | |
| Preventice Services, LLC | $15.64 | 2019 | |
| Cvrx, INC. | $14.29 | 2025 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $13.29 | 2020 | |
| Daiichi Sankyo INC. | $12.62 | 2022 | |
| Escala Medical INC. | $6.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Memon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.